| Literature DB >> 23354937 |
Kenji Miyamoto1, Masahide Fujisawa, Hajime Hozumi, Tatsuo Tsuboi, Shigeko Kuwashima, Jun-ichi Hirao, Kenichi Sugita, Osamu Arisaka.
Abstract
Respiratory syncytial virus (RSV) is a cause of neurological complications in infants. We report a rare case of RSV encephalopathy in an infant who presented with poor sucking and hypothermia at 17 days of age after suffering from rhinorrhea and a cough for several days. After hospitalization, the patient presented with stupor and hypotonia lasting for at least 24 h, and was intubated, sedated, and ventilated for treatment of pneumonia. These symptoms led to diagnosis of pediatric systemic inflammatory response syndrome (SIRS) caused by RSV infection. High-dose steroid therapy was combined with artificial ventilation because the initial ventilation therapy was ineffective. Interleukin (IL)-6 levels in spinal fluid were markedly increased upon admission, and serum IL-6 and IL-8 levels showed even greater elevation. The patient was diagnosed with RSV encephalopathy. On day 5, high signal intensity in the bilateral hippocampus was observed on diffusion-weighted magnetic resonance imaging (MRI). On day 14, the patient presented with delayed partial seizure and an electroencephalogram showed occasional unilateral spikes in the parietal area, but the hippocampal abnormality had improved to normal on MRI. (99m)Tc-labeled ethylcysteinate dimer single-photon emission computed tomography (SPECT) on day 18 showed hypoperfusion of the bilateral frontal and parietal regions and the unilateral temporal region. SPECT at 3 months after onset still showed hypoperfusion of the bilateral frontal region and unilateral temporal region, but hypoperfusion of the bilateral parietal region had improved. The patient has no neurological deficit at 6 months. These findings suggest that RSV encephalopathy with cytokine storm induces several symptoms and complications, including SIRS and prolonged brain hypoperfusion on SPECT.Entities:
Mesh:
Year: 2013 PMID: 23354937 PMCID: PMC3824296 DOI: 10.1007/s10156-013-0558-0
Source DB: PubMed Journal: J Infect Chemother ISSN: 1341-321X Impact factor: 2.211
Laboratory data at admission
| Peripheral blood | Arterial blood gas analysis (FiO2 0.30–0.45) | ||
| WBC | 20,200/μl | pH | 7.228 |
| Nt | 31 % | PaCO2 | 69.4 Torr |
| Ly | 47 % | PaO2 | 72.7 Torr |
| Mo | 10 % | HCO3 − | 27.9 mmol/l |
| Eo | 2 % | BE | −0.1 mEq/l |
| Ba | 0 % | Serology | |
| RBC | 305 × 104/μl | CRP | 3.87 mg/dl |
| Hb | 10.1 g/dl | Procalcitonin | 0.77 ng/ml |
| Ht | 32.4 % | IgG | 853 mg/dl |
| Plt | 52.7 × 104/μl | IgM | 32 mg/dl |
| Biochemistry | IgA | 5 mg/dl | |
| TP | 6.7 g/dl | Ferritin | 8163 ng/ml |
| Alb | 4.1 g/dl | IL-6 (<4 pg/ml)a | 304 pg/ml |
| AST | 192 U/l | Serology during hospitalization | |
| ALT | 160 U/l | IL-1β (<10 pg/ml)a | <200 pg/ml |
| T-bil | 1.3 mg/dl | IL-8 (<2 pg/ml)a | 115 pg/ml |
| LDH | 1359 U/l | IL-10 (<5 pg/ml)a | <20 pg/ml |
| CK | 439 U/l | MCP-1 (200–722 pg/ml)a | <625 pg/ml |
| BUN | 12 mg/dl | TNF-α (0.6–2.8 pg/ml)a | <5 pg/ml |
| Cre | 0.24 mg/dl | Cerebral spinal fluid | |
| Na | 122 mEq/l | IL-6 (<0.4 pg/ml)a | 102 pg/ml |
| K | 5.8 mEq/l | Viral culture | (–) |
| Cl | 89 mEq/l | Protein | 88 mg/dl |
| Glucose | 55 g/dl | Cell count | 2/μl |
| Culture | – | – | |
| Blood | (–) | – | – |
| Spinal fluid | (–) | – | – |
| Nasal |
| – | – |
aNormal value or range. IL-6 was measured using Human IL-6 CLEIA (Fujirebio, Japan). IL-1β, IL-8, and IL-10 were measured using BIOSOURCE IL-1β, IL-8, and IL-10 ELISA kits (BioSource Europe, Nivelles, Belgium). MCP-1 and TNF-α were measured using Human MCP-1 and TNF-α Immunoassay kits (R&D Systems, Minneapolis, MN, USA)
Fig. 1Magnetic resonance imaging (MRI) on day 6. Diffusion-weighted imaging (DWI) (a) revealed bilateral high-intensity regions in the hippocampus, and the apparent diffusion coefficient (ADC) (b) was low in the same regions. c–f 99mTc- ethylcysteinate dimer (ECD) single-photon emission computed tomography (SPECT). Axial views through the parietal lobes (c, e) and through the cerebral cortex, white matter, and basal ganglia (d, f). Upper row (c, d): At 18 days after onset (hospital day 18), SPECT showed hypoperfusion of the bilateral frontal and parietal lobes and the unilateral temporal lobe with some predominance on the left side. Lower row (e, f): At 3 months after onset, hypoperfusion of the bilateral parietal lobes on SPECT had improved, but hypoperfusion of the unilateral temporal lobe with some predominance on the left side was exacerbated